Product information
Dehydronifedipine
- CAS No.
- 67035-22-7
- Formula
- C₁₇H₁₆N₂O₆
- Molecular weight
- 344.32 g/mol
Backed by process development and scale-up capabilities, Capot can provide stable kilogram-to-commercial-scale supply of Dehydronifedipine and support custom specifications.
Product overview
Dehydronifedipine is an oxidized pyridine analogue of nifedipine with a nitrophenyl substituent and two methyl carboxylate groups.
Application areas
Depending on the synthesis route and project requirements, this product may also be suitable for other related organic synthesis applications.
Potential uses
- Dehydronifedipine is used as a pharmaceutical impurity reference material for nifedipine testing; it is also designated nifedipine impurity A.
Typical specifications
| Item | Typical specification |
|---|---|
| Purity | NLT 98% |
Specific quality parameters can be confirmed based on project and application requirements. The final product specifications are those agreed upon by both parties.
Production & quality support
Quality support
- Process development, optimization and scale-up
- Analytical testing and quality control
- Batch documentation and technical information support
Scale & supply
- Commercial manufacturing and supply capabilities from kilogram to ton scale
- Assessment of customer specifications and quality requirements
- Long-term reliable supply support
Supply scale：Evaluated based on project requirements
Available documents
- Product specification (SPEC)
- Safety data sheet (SDS)
- Certificate of analysis (COA)
- Route of synthesis (ROS)
- Method of analysis (MOA)
- Analytical data
- Regulatory and quality declarations
Related documents may be evaluated and provided based on the product, project stage, progress of cooperation, and confidentiality requirements.
Website information is for reference only. For product specifications and related materials, please refer to the final official documents confirmed by our company.
Custom requirements
Start a conversation
Request a quote
Tell us the quantity and technical requirements. We will follow up shortly.